Cardiogen
- Category
- Bioregulators
- Administration routes
- InjectableOral
- Regulatory status
- Not FDA-approved
What it is
A short synthetic bioregulator peptide marketed for heart health and cardiac anti-aging. Evidence is almost entirely animal and cell-culture: reduced heart-cell death and better survival after induced heart injury, with human data essentially absent. Animal work also shows it altering tumor-cell behavior, an unresolved concern for undiagnosed cancer, with no human safety record. Not an approved drug in the US; supply is unregulated research-grade material.
Read Full recordStudied uses & evidence
Studied uses(11)
Stimulates expression of cytoskeletal proteins (actin, tubulin, vimentin) by 2-5x in fibroblast cultures
SpeculativeSingle mouse embryonic fibroblast study only, not replicated, not cardiac tissue.
Enhances nuclear matrix protein expression (lamin A, lamin C) by 2-3x
SpeculativeSame single embryonic fibroblast experiment, no independent confirmation or human data.
Stimulates cardiomyocyte proliferation in organotypic tissue cultures from both young and aged animals
LowTwo ex vivo rat tissue culture studies show increased proliferation in young and aged hearts.
Evidence limits
- Evidence Level
- Preclinical
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
General cautions
Pregnancy or breastfeeding
AbsoluteNo human reproductive safety data exists for this peptide. Effects on fetal development are unknown.
Children under 18
AbsoluteNo pediatric safety data. Not recommended for use in minors.
Known hypersensitivity
AbsoluteDiscontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).
Risk summary(8)
Risks = level of concern: High · Moderate · Low · Theoretical
safety_data
ModerateUnknown long-term safety profile in humans
ModeratePossible immunogenic reactions (as with any exogenous peptide)
LowPotential unknown interactions with cardiovascular medications
TheoreticalGene expression modulation effects could theoretically have unintended consequences
TheoreticalTumor-modifying activity observed in animal models raises questions about effects in patients with undiagnosed cancers
Moderatecontraindications
Moderatenote
Low
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.